CDK13 and glioblastoma: Moreover, in agreement with the oncogenic behavior conferred by CDK13 editing described herein, the CDK13 editing event (c.308A > G) has been found to be overrepresented in several tumor types as compared with normal control samples, such as hepatocellular carcinoma [67], glioblastoma [68] and kidney renal clear cell carcinoma [7].